Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin vs Ketamine for Alcohol Use Disorder
NCT05421065Phase 2Active, not recruiting
- Start
- Feb 2024
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in alcohol use disorder (AUD). Started Feb 2024; status: active, not recruiting.
02
Drugs
psilocybin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05421065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05421065.